The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

NEW YORK, Sept. 20, 2024 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up ...

according to data presented at the European Society for Medical Oncology 2024 Congress (ESMO 2024) in Barcelona, Spain, and published concomitantly in the Journal of Clinical Oncology. Patients ...

For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer ...

For patients with advanced melanoma, there is a survival benefit for nivolumab plus ipilimumab and for nivolumab monotherapy ...

Bowers added that to increase access to the latest drugs, the "cancer system" must be organized in such a way as to ...

Today we highlight research findings reported at ESMO 2024, the annual meeting of the European Society of Medical Oncology.

The FDA has expanded its approval of Kisqali, a drug already approved to treat advanced breast cancer, to include women with ...

A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...